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Abstract
Homo obesus (Man the obese) is known to have differences in cardiometabolic profile 
compared to wild type H. sapiens (Man the wise). To explore the differences in the affect 
of trauma upon H. obesus a thorough literature search was performed. in this review 
evidence is brought together to show the differences in injury patterns seen between 
H.  obesus and wild type H. sapiens, the differences in outcome following trauma and 
how the altered adipokine and osteokine profile of H. obesus influences his bone struc-
ture. we see that the obese state is a risk factor for both increasing severity of limb 
trauma and increased mortality, critical care length of stay and death following blunt 
trauma. This risk may be influenced by the abnormal adipokine profile. in particular the 
roles of adiponectin, leptin, PPARγ, TNF-α and iL-6 are considered. The effect of chronic 
inflammatory insult prior to trauma in the obese adult is considered and its potential 
influence over the outcome is debated. Following major blunt trauma the robust ap-
pearing physique of H.  obesus shows it’s fragility with an increased risk of death and 
longer hospital stay. 
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Introduction
The concept of Homo obesus was first 
introduced in 2007 (1). It describes a 
phenotypic variant of H. sapiens char-
acterized by obesity – probably – due 
to deficiency in metabotrophic factors, 
such as adiponectin, nerve growth fac-
tor (NGF), brain-derived neurotroph-
ic factor (BDNF), interleukin (IL-10), 
responsible for the homeostasis of 
glucose and lipids metabolism and of 
cardiovascular and immune system. 
H. obesus also has abnormal inflam-
matory activity and is at risk of meta-
bolic diseases such as type 2 diabetes 
and atherosclerosis. As H. obesus ages 
and develops type 2 diabetes, he/she 
may begin to dement and a common 
pathway may lead onto Alzheimer’s 
disease (2).
Homo obesus is clearly not a healthy 
phenotype and through his own me-
tabolism may progress to ill health. To 
observe H. obesus we see a large solid 
frame, a robust appearing structure 
capable of independent locomotion 
and having the physical strength to 
carry this bulk from place to place. 
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It may not be as fast as wild type H. sapiens but the effort and 
strength shown are greater. Despite these outward appearanc-
es, H. obesus may be more fragile than we think and may be at 
higher risk of injury than H. sapiens. However, as we shall see, 
nothing in nature is clear and H. obesus may be at higher risk of 
injury or may have some protection from injury.
Risks of injury to Homo obesus
Most children do not sustain a fracture during their childhood. 
Of those fractures that are sustained some 66% occur in children 
who have already had one fracture during their short lives. Most 
of these fractures will be treated as outpatients and will have 
occurred during play or sport rather than being due to severe 
trauma. Commonly, fractures occur at times of peak bone turn-
over such as early puberty. It has been suggested that risk factors 
include poor nutrition, lack of physical exercise, and obesity. In 
apparently normal children with fractures bone mineral density, 
bone accrual and bone size are smaller than those without frac-
tures (3,4). Obese children with a history of fractures have been 
shown to have a lower total bone mineral density (BMD) and a 
lower bone mineral content for lean mass (5,6). It is suggested 
that fat mass substantially inhibits bone accrual in children with 
previous fractures (6).
The overall risk of injury to the obese child may not be high-
er than the non obese population but certain regions are more 
commonly injured in certain circumstances. In motor vehicle 
collisions, occupants aged 9-15 who are overweight have been 
seen to be at higher risk of lower and upper limb injuries than 
their normal weight counterparts. This may be due to a differ-
ence in biomechanical forces applied to the larger frame of the 
overweight child involved in a vehicle collision (7). The extrem-
ity injury acquired is more likely to require operative interven-
tion in the overweight child and the child is at higher risk of 
complications such as venous thromboembolic disease and 
decubitus ulceration than the normal child (8). Outside of the 
higher energy trauma setting; based upon bone mineral density 
measurements, obese boys have been shown to be at higher risk 
of forearm fracture than non-obese, even when controlling for 
lower fall heights and softer impact surfaces (9). When the adi-
posity is formally measured in patients with distal forearm frac-
tures, it has been shown that increasing levels of adiposity and 
decreasing levels of lean mass are associated with fractures (10). 
As H. obesus matures, a clear association between increas-
ing BMI and increasing risk of injury has been shown (11). 
Mathematical modeling of the posture of H. obesus has found 
that the altered centre of gravity, compared to wild type H. sapi-
ens, can lead to a higher risk of falling (12). This is something that 
H. obesus can be aware of. Fear of falling is an important prob-
lem in mobility of higher functioning older patients and is as-
sociated with reduced levels of physical activity (13). Decreased 
weight bearing activity is known to be associated with a decrease 
in bone mineral density in the elderly (14) and the young (15). 
A range of social and psychological risk factors are positively as-
sociated with fear of falling and obesity is one proven risk factor 
which can be important in removing fear of falling and encour-
aging load bearing exercise (16).
Fear of falling does not affect all people. What effects upon the 
bone are seen in the more mobile H. obesus? Clearly, if H. obesus 
is to be mobile then the skeletal system must be strong enough 
to carry the increased weight. We have seen that load bearing 
exercise increases bone mineral density. It has been found that 
severe obesity (BMI >35 kg/m2) increases volumetric bone min-
eral density and cortical bone mineral content but lower corti-
cal BMD (17). Much attention is given to low BMD and post 
menopausal women are the group most often investigated with 
bone mineral density scanning. What of high BMD? A large 
study of over 16,000 women has shown that high BMD is closely 
associated with high BMI (18). It is not only the fat content that 
contributes to increased bone mineral density, lean mass has 
been shown to be an important contributor too (19). This rela-
tionship has not been observed in non-caucasion women. It has 
been found that African American women with increasing BMI 
have a slight but significant decrease in bone mineral density 
(20). Most commonly it is the load bearing bones of the lumbar 
spine and femoral neck that are scanned for bone mineral den-
sity. Outside of these load bearing areas, we could expect the in-
creased mechanical loading effect of H. obesus to be eliminated 
as a factor influencing bone mineral density. Prior to menopause 
obesity does not predict bone mineral density in the distal fore-
arm (21). Increased bone mineral density related to the obese 
state appears to be transient, lasting as long as the obese state 
lasts. It has been seen, in a relatively small randomized control-
led trial, that weight loss even when combined with exercise in 
obese adults results in a decrease in BMD (22).
If increased BMI is related to increased bone mineral density 
in some groups, could obesity have a protective effect against 
osteoporosis? The literature is sparse and contradictory. Based 
upon lumbar vertebral bone mineral density, an association has 
been seen between lower BMD and higher BMI (23). Increased 
BMI has shown a protective effect against hip fracture but a 
higher risk of humerus fracture, whereas low BMI has appeared 
as a risk factor for hip fracture and not for humerus fracture 
(24). We can consider possible reasoning for this. A higher BMI 
will increase load bearing through the femoral neck and thus 
increase cortical bone mineral density. The result: a stronger 
and more robust bone able to withstand higher impact forces. 
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etry and decrease in mineral density account for a significant 
change in bone strength (35). Recently it has been seen that al-
though obesity may have some protective effect in adults against 
fractures, in children it seems to be a risk factor for fractures. 
Bone characteristics of mice were assessed after a high fat diet 
and it was found the bone quantity and bone quality were im-
portant determinants of bone strength. Thus, the obese patient 
may have higher mineral content and bone turnover but the 
quality of the bone maybe reduced in such a way that it loses 
some mechanical strength (36,37). 
See Editorial on page 73-75
How do injury patterns in Homo obesus differ?
Obese children appear to be more likely to sustain a lower ex-
tremity injury then their non-obese counterparts (7,8,38). 
Interestingly, these children seem less likely to suffer head or 
facial injuries. Those that do require operative management of 
femoral fractures are at higher risk of complications (39). In the 
adult population, following motor vehicle collisions, obese pa-
tients have been found to have significantly more severe distal 
femur fractures than non-obese patients (40).
Obesity is associated with a significantly higher likelihood of 
an ankle fracture being more severe and requiring manipulation 
or operative fixation (41,42). As well as being a risk factor for 
needing manipulation of the fractured ankle, obese patients have 
a higher risk of this manipulation failing or of internal fixation 
failure needing revision surgery (43). In the upper limb elbow 
fractures requiring surgery are associated with obesity (42) as 
are humeral fractures (24) and of those who do sustain humeral 
fractures, obesity is a risk factor for non-union (44).
Outside of the skeletal system head injuries have been looked 
at in obese and non obese adults involved in frontal motor ve-
hicle collisions. An Italian study of close to 6,000 patients found 
that obese passengers were more likely to sustain a more severe 
head trauma than non obese passengers following collision (45). 
It had been hypothesized that obesity in patients with head in-
juries would potentially lead to a poorer outcome. However an 
American study did not support this hypothesis. Obese patients 
with head injury did not have a higher mortality or morbidity. 
Instead the increases in mortality and morbidity could all be ac-
counted for by increasing age, lower admission blood pressure 
and concurrent chest injury (46).
Does obesity confer any protective advantages against injury? 
A protective affect of obesity has been suggested when consider-
ing pelvic fractures. An American study looking at side impact 
motor vehicle collisions identified lower BMI as a risk factor for 
A lower BMI does not confer this load bearing advantage. The 
humerus however, is not a load bearing bone, it may be involved 
in levering the frame of H. obesus into a standing position but 
prolonged load bearing is not a regular occurrence, thus BMD is 
not increased in the same way as the femoral neck. The result: a 
substantial impact to the humerus caused by Homo obesus fall-
ing is enough to break the humerus. Another recent study has 
demonstrated a protective effect of higher BMI towards femoral 
neck fractures but not towards upper extremity or less well pad-
ded lower extremity fracture sites (25). 
Could we hypothesise that normal BMD for wild type H. sa-
piens is abnormally low for H. obesus? Perhaps we can. There 
is evidence that most obese woman with low energy trauma 
fractures have what is regarded as normal BMD for the general 
population of their age. In this particular study, the prevalence 
of obesity and morbid obesity was surprisingly high (26). Men 
show similar findings. Obesity is not uncommon in older men 
and when BMD is held constant, obesity is associated with in-
creased fracture risk (27). Amongst those women who do have 
osteoporosis, both increasing weight and increased BMI have 
been shown to be risk factors for vertebral fractures (28). 
Homo obesus is at increased risk of developing type 2 diabe-
tes and related cardiometabolic diseases (1). Does this have any 
influence upon bone mineral density or fractures? It was found 
that patients with non insulin dependant diabetes had a higher 
bone mineral density than those with normal glucose tolerance, 
this difference could not be explained by obesity or several other 
factors. It was also seen that women in this group had a lower 
incidence of non-vertebral fractures while in men there was no 
difference in fracture frequency (29). Again as time passes so 
the literature evolves and by 2001 a larger prospective study of 
postmenopausal women found that having or developing diabe-
tes put women at higher risk of hip fracture than non-diabetic 
women (30). A large historical cohort study performed in 2008 
also found that diabetic patients had a higher risk of fractures 
overall and hip fractures specifically, compared to non-diabetics 
(31). The incidence of vertebral fractures appears to be increased 
in type 2 diabetes in both men and women. In men, despite hav-
ing apparently normal bone mineral density, the combination of 
hyperglycaemia and obesity has been identified as a significant 
risk factor for vertebral fracture in diabetic men (32). 
The metabolic syndrome has been inconsistently identified as 
a risk factor for osteoporotic fractures but was also associated 
with a higher BMD (33) and also associated with lower BMD 
and lower fracture risk (34).
Bone mineral density is but one contributor towards bone 
strength. It has also been seen that structural geometry of the 
bone influences bone strength and together alterations in geom-
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pelvic fractures, where as obesity appears to show a protective 
affect (47). In children it has been found that obesity is associ-
ated with a lower risk of intracranial and intraabdominal inju-
ries after trauma (8). Of those obese adults who do sustain a 
pelvic ring injury, should it need operative fixation, then BMI 
correlates with an increase risk of complication and re-operation 
(48,49).
It seems then, that H. obesus can be at a higher risk of sustain-
ing a more severe and complicated lower or upper limb injury 
than his non obese counterpart. There does not appear to be any 
difference in head injuries and obesity may offer some protec-
tion against pelvic injury. However, should surgery be needed 
for the pelvic injury then the likliehood of complications is high-
er in H. obesus.
Outcome for the critically injured Homo obesus
Should the trauma sustained be severe enough, H. obesus may 
enter the critical care environment. In this highly specialized 
area of the hospital we find the sickest patients. How does the 
obese state influence the critically injured H. obesus?
Although some literature exists suggesting that obesity sig-
nificantly increases both morbidity and mortality in the obese 
critically ill trauma patient (50) the weight of published litera-
ture suggests that obesity itself does not increase mortality in the 
critical care environment (51-57). Obesity may influence length 
of stay in the critical care unit (51,57,58) and also may influence 
prolonged duration of mechanical ventilation (51). 
Outside of the specific group of patients found in critical care 
environments, obesity may have some influence on overall sur-
vival of the injured H. obesus. Injury may be so severe that death 
occurs before reaching the critical care environment or condi-
tions may alter during surgery or on a normal ward resulting 
in death before reaching the critical care unit. Again, literature 
exists to support either the hypothesis of increased mortality as-
sociated with obesity (59) or the hypothesis that obesity does not 
influence mortality (60,61).
When grouped on mechanism of injury those who have sus-
tained blunt trauma, as opposed to penetrating trauma, a study 
over 1,000 such patients found a few differences between obese 
and non-obese subjects. The obese were more likely to have low-
er extremity injuries, chest injuries, increased lengths of hospital 
stay, higher complication rates and longer lengths of ventilation 
than the non-obese. Also, in this group, obesity was identified 
as a risk factor for mortality (62). A case control study has again 
identified obesity as an independent predictor of mortality fol-
lowing blunt trauma (63). This increased mortality confirmed 
a finding of some years earlier of increased mortality in blunt 
trauma patients that were severely over weight despite advanc-
es in trauma care in the last 15 years (64). A further study that 
found increased mortality among morbidly obese trauma pa-
tients was able to show that mortality increased in the morbidly 
obese when injury progressed from a single organ system failure 
to a multi-organ system failure (65). 
Adipobiology and the skeleton of Homo obesus
Adipose tissue plays a central role in energy homeostasis and 
in recent times has become recognized not as an inert stor-
age for triglycerides but as an active endocrine organ (1). 
Adipoproteomic analyses have identified more than 100 mul-
tifunctional secretory proteins collectively termed adipokines 
(66). Through endocrine and paracrine pathway they influence 
metabolic, vascular, inflammatory and cognitive processes. 
Adipokines include leptin, adiponectin, cytokines such as tu-
mor necrosis factor-alpha (TNF-α), IL-6, IL-10, IL-18, IL-32, 
visfatin, apelin, neuropeptides and neurotrophins (NGF, BDNF) 
amongst others; obese individuals have higher levels of pro-in-
flammatory adipokines and lower levels of the metabotrophins 
adiponectin, NGF and BDNF (1,66).
Adipose tissue and bone are linked by several biochemical 
pathways which ultimately result in a skeleton of appropri-
ate structure and strength to support the soft tissue mass and 
provide locomotion for the individual. Recently, bone-derived 
secretory proteins collectively designated osteokines were rec-
ognized (67); via endocrine pathway, they exert control on vari-
ous extrabone processes including glucose and lipid metabolism 
(Gumpeny and Gumpeny in this volume of Adipobiology, also 
see 68).
How do the well documented adipokines influence bone 
metabolism? 
Leptin
Leptin is produced mainly by the adipocytes (66) but also in low 
levels by gastric fundal epithelium, intestine, placenta, skeletal 
muscle, mammary epithelium, brain, and bone cells. Leptin 
levels are related to energy stores such that they are increased 
in obesity and decreased in fasting states. With respect to bone, 
leptin has been seen to cause and increase in bone formation, 
indeed a positive correlation is seen between serum leptin levels 
and BMD (69). Acting upon the central nervous system via the 
JAK-STAT pathway, leptin has influence upon bone and carti-
lage growth. Leptin also has direct effects upon osteocytes that 
express leptin receptors leading to osteoblast proliferation and 
maturation, osteoclast development, and chondrocyte activity 
(70,71). Leptin influences the GnRH and GHRH pathways at the 
pituiatary and hypothalamic levels. Leptin has been seen to have 
inhibitory actions on somatostatin relaease and increase in GH 
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release. GH release leads to the release of IGF-1 which in turn 
stimulates the growing pates of bones. Via its influence on the 
GnRH pathway, leptin influences pubertal bone growth. Obese 
children are often taller prior to puberty but have earlier onset of 
puberty. Leptin levels have been seen to rise prior to puberty by 
50% suggesting that leptin may influence the onset of puberty by 
increasing GnRH secretion. As well as acting via central effects, 
leptin receptors have been found in growth plates, implying that 
leptin can act peripherally to increase bone growth (72).Those 
who have a growth hormone deficiency have short stature and 
reduced bone mineral density but increased adiposity and lep-
tin levels. Central leptin administration has been seen to impair 
trabecular bone formation while peripheral leptin has been seen 
to enhance cortical mineral accrual. These conflicting results 
may suggest that an important balance between central and pe-
ripheral leptin effects final bone strength and leptin has differing 
influences upon different parts of the bone microstructure (37).
Adiponectin
Adiponectin is the most abundant protein secreted by adipose 
tissue and has a higher concentration in the circulation than 
other secreted cytokines. Unlike leptin, adiponectin levels are 
decreased in the obese state, its levels increase during weight 
loss. Adiponectin has been shown to have a negative effect upon 
both BMD and bone mineral content (73). It has been shown 
in vitro that adiponectin concentrations may alter bone mineral 
accrual by modulating insulin action upon bone. Adiponectin 
levels inversely correlate with adiposity, therefore it is possible 
that the obese state removes negative influence upon bone min-
eral accrual and thus leads to a higher BMD (73). The higher 
BMD seen in type 2 diabetes is associated with higher levels of 
circulating insulin. 
PPAR gamma
Perioxisome proliferator-activated receptor gamma (PPARγ) 
is one of three nuclear receptors of the PPAR class, that is wide-
ly expressed but found predominantly in white adipose tissue. 
Several classes of ligands for PPARγ have been described and 
include poluyunsaturated fatty acids (e.g. arachidonic acid), 
prostaglandin like compounds, oxidized lipids and the phar-
macological agents, the thiazolidine compounds (74,75). It has 
been shown that women with osteoporosis have and increased 
accumulation of bone marrow adipocytes, as seen on iliac crest 
biopsies (76,77). Both osteoblasts and adipocytes derive from 
a common origin, the mesenchymal stem cells. In mice, it has 
been seen that an increase in marrow adipocytes is correlated 
with an increase in expression of PPARγ2 and it has also been 
seen that PPARγ2 expression can direct preosteoblast cell lines 
to become adipocytes rather than osteoblasts (78,79). Aging 
heterozygote PPARγ knockout mice have been seen to have an 
increased number of osteoblasts and bone formation along with 
a lower number of marrow adipocytes when compared to aging 
wild type controls (80). Senesence accelerated strain mice have 
also been seen to have both increased levels of bone marrow 
adipocytes and mRNAPPARγ2 (81). The PPARγ has recently been 
shown to be phosphorylated by overfeeding mice. Although 
this does not alter the adipogenic capacity of PPARγ, it has led 
to dysregulation of other adipogenic genes including reduced 
expression of adiponectin (82). In humans it has been seen 
that adiponectin mRNA levels were positively associated with 
mRNAPPARγ in obese and diabetic patients, leading to the sugges-
tion that adiponectin could be regulated by PPARγ in man (83). 
PPARγ is also a receptor for the protein nocturin. This circadian 
protein has been shown to enhance PPARγ transcriptional ac-
tivity while mice deficient in nocturin are protected from obes-
ity and have lower levels of bone marrow adipocytes (84).
Interleukin-6
Interleukin-6 has been shown to be produced by adipose tissue, 
accounting for around 1/3 of the total IL-6 produced without ac-
tive inflammatory processes. In the obese, higher base line levels 
of IL-6 are seen when compared to non-obese (85-87). Through 
a stimulatory effect upon the osteoclast lineage, IL-6 has become 
acknowledged as an osteoporotic factor (88).
TNF-α
Tumor necrosis factor-alpha has been shown to increase leptin 
production by adipocytes (89), and is associated with insulin re-
sistance. Higher levels of TNF-α have been seen in both diabet-
ics and obese (87,90). It has also been seen that with weight loss, 
the circulating TNF-α levels of obese subjects decrease and the 
degree of insulin resistance also falls. Therefore, with weight loss 
we could expect the the influence of TNF-α upon leptin expres-
sion to also decrease and thus the level of expressed leptin to de-
crease.90 In the obese state then, it seems that higher leptin levels 
acting both centrally and peripherally can increase bone mineral 
density and bone formation rate but may impair trabecular bone 
structure. Lower adiponectin levels reduce the negative effect of 
adiponectin upon bone mineral accrual and lead to higher bone 
mineral density. The lower levels of adiponectin associated with 
obesity are further influenced by altered activity of PPARγ in 
the obese. Higher levels of IL-6 in the obese lead to stimulation 
of osteoclasts, whilst higher levels of TNF-α further stimulate 
leptin release. The balance between these processes will influ-
ence the rate of bone turnover and it is known that at periods of 
higher bone turnover fracture risk is increased (3). 
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 How does, if any, trauma to the body of H. obesus alter the 
adipokine profile? Following minimal trauma it has been shown 
that subcutaneous adipose tissue releases an increased amount 
of IL-6, up to 20 fold compared to the resting state while TNF-α 
increased by just over 50% (91). A significant positive correla-
tion between injury severity scoring and initial IL-6 concentra-
tions has been seen and of those patients who develop multi-
oragn failure after trauma, a significant difference between 
IL-6 and TNF-α levels is seen 1 day prior to death, compared 
to multiorgan failure survivors (92). IL-6 has been shown to be 
a potential predictive factor of the future development of mul-
tiorgan failure in the patient with hypovolaemic shock.93 After 
the controlled trauma of surgery, IL-6 concentrations have been 
seen to increase from baseline levels and in the obese these base 
line and post operative levels have been seen to be related to ab-
dominal adipose tissue content. Postoperative worsening of in-
sulin resistance is associated with increasing plasma and adipose 
IL-6 levels (94). Similarly TNF levels have been seen to increase 
after hypovolaemic shock in rodent models. By resuscitating 
these models using resuscitation fluid containing ethyl pyruvate, 
TNF levels were seen to be suppressed and survival increased 
compared to models receiving standard resuscitation fluids only 
(95). Adiponectin has been shown to be low in trauma patients 
and critically ill patients due to an as yet unknown mechanism, 
suggesting that adiponectin may have a role in the inflammatory 
response to trauma (96,97).
 It has been postulated that the higher base line levels of pro-
inflammatory adipokines seen in the obese patient may account 
for the excess mortality seen in the obese following critical in-
jury. At first sight it appears to stand to reason that if levels of 
pro-inflammatory cytokines are initially high then, the adding 
on a further inflammatory response will inevitably worsen the 
inflammatory response and outcome. Recent evidence has not 
supported this view. It would seem that the magnitude of in-
flammatory response following trauma, for example, a 20 fold 
increase in IL-6, is so high that any base line alterations in in-
flammatory profile due to obesity are overwhelmed. Resolution 
of this inflammatory response in the period following injury 
may differ between patients of differing BMI but at present there 
is no published literature to support or refute this possibility 
(98,99).
Conclusion
Homo obesus is a creature with bone structure different to that 
of wild type H. sapiens. The mineral content and density may 
be higher in H. obesus but the trabecular bone structure may 
not be as strong. The differing levels of adipokines circulating 
in H. obesus may lead to an increased bone turnover rate and 
unusual microstructure altering the density and strength of the 
bone. While the BMD may be increased when compared to 
wild type H. sapiens it may not have increased enough to of-
fer a significant protective effect from the increased impact as-
sociated with a fall. In the weight bearing bones of mobile H. 
obesus an increase in strength is seen. Obese children are at 
higher risk of sustaining a lower limb fracture than non-obese 
children. Obese adults involved in motor vehicle collisions are 
at higher risk of sustaining more severe distal femur fractures. 
Obese adults who sustain ankle fractures are more likely to 
have more severe injuries and need manipulation or surgical 
fixation and this intervention has a higher rate of failure than 
in the non-obese. Obesity is a risk factor for upper limb frac-
tures of the elbow, humerus and forearm. Obese adults are at 
higher risk of head injury in motor vehicle collisions. A protec-
tive effect is seen however against osteoporosis, based on cur-
rent definitions for the population, and against sustaining pel-
vic ring fractures following motor vehicle collisions. In obese 
children a lower rate of head and abdominal injuries is seen. 
Should H. obesus require the facilities of the critical care unit it 
is likely that he will spend longer there than his non obese com-
panion and may need a prolonged period of mechanical ven-
tilation. Overall H. obesus suffering blunt trauma has a higher 
morality, and higher rates of extremity injury, chest injury and 
longer lengths of hospital stay. While the increased level of adi-
posity seen in H. obesus leads to higher base line levels of pro-
inflammatory adipokines, compared to the non-obese (and in 
the case of adiponectin lower levels) this does not seem to be 
a suitable explanation for the excess mortality of H. obesus as, 
following blunt trauma, the magnitude of the trauma inflamma-
tory response overwhelms the modest sub-clinical increase in 
these cytokines.
 In short, H. obesus is at higher risk of injury than wild type H. 
sapiens. This risk may be influenced by the abnormal adipokine 
and/or osteokine profile. This injury is likely to be more severe 
especially if it is a limb injury. Following major blunt trauma the 
robust appearing physique of H. obesus shows it’s fragility with 
an increased risk of death and longer hospital stay. 
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